KAPA Latest Press Releases

-- November 5, 2026 --

Kairos Pharma Recognized by Biotech Breakthrough Awards in Oncology Business Wire 9:15 AM

-- November 3, 2026 --

Kairos Pharma Presents at United Scientific Group's 11th International Conference on Cancer Research & Drug Development Business Wire 11:45 AM

-- October 6, 2026 --

Kairos Pharma Reports Positive, Statistically Significant Interim Efficacy Data from Phase 2 Trial of ENV-105 in Metastatic Prostate Cancer Business Wire 7:30 AM

-- September 23, 2026 --

Kairos Pharma to Present and Moderate at Discovery on Target Conference in Boston, MA Business Wire 8:00 AM

-- September 9, 2026 --

Kairos Pharma to Present at the H.C. Wainwright 28th Annual Global Investment Conference Business Wire 8:00 AM

-- August 21, 2026 --

Kairos Pharma Announces 1-for-7 Reverse Stock Split Business Wire 4:30 PM

-- July 22, 2026 --

Kairos Pharma Announces Strategic Collaboration with Bayer to Enhance XOFIGO Activity in Metastatic Prostate Cancer Business Wire 8:35 AM

-- July 15, 2026 --

Kairos Pharma Reports Breakthrough Interim Safety Data in Phase 1 Trial of ENV-105 in EGFR-Mutated Lung Cancer Patients - Targeting a $10 Billion Drug Resistance Market Business Wire 8:30 AM

Market Data Delayed 15 Minutes